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in South Africa: CSIR case
Bareetseng, Sechaba＊ and YAMANA, Mika＊＊
Summary
The focus of this paper is traditional knowledge (TK) and indigenous biological resources 
protection in South Africa, through the analysis of the existing policies and legislations, in order to 
provide a useful insight for a developed country such as Japan which has recently adopted the 
guidelines for the protection of TK and biological resources and promotion of access and benefit 
sharing (ABS). South Africa is the 3rd most diverse country in terms of natural resources, culture 
and traditions, languages and geology and its comprehensive legislative framework system shows 
the country’s seriousness to safeguard TK and conserve biological resources for future 
generations.
The paper uses the South Africa’s government owned research and technology development 
institution, Council for Scientific and Industrial Research (CSIR), as an example to demonstrate the 
application of the TK protection and biodiversity conservation (including access and benefit 
sharing) laws, through case studies approach for lessons learned for other African countries, 
contemplating creation of their own TK protection and environmental conservation. Due to the 
repositioning of CSIR within the local and global research and develop, the organisation has 
adopted Industrialisation Strategy, and TK will play a significant role in technology development 
and new business models in rural agroprocessing and production to enhance inclusive 
development (through benefit sharing) and support economic growth.
The paper concludes that TK and indigenous biological resources protection through the relevant 
government laws, as well as value addition to TK and biodiversity through research and 
development supported by government funding, is necessary for socioeconomic attainment, 
especially for local and indigenous communities and rural agroprocessing businesses as part of 
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benefit sharing.
1. Introduction
The advancement in scientific knowledge and technological changes over centuries has brought 
profound societal changes. Through new international regimes, knowledge has become a 
commodity to be bought and sold. At the same time, traditional knowledge has also continued to 
develop, though at a different pace, especially in the developing countries.
South Africa is one of the most diverse countries in the world, in terms of the natural resources, 
geology, culture, people and languages. There are 11 official languages in South Africa: English, 
Afrikaans, IsiZulu, IsiXhosa, IsiNdebele, SiSwati, Sepedi or Sesotho, Tshivenda, Xitsonga, Sesotho 
sa Borwa and Setswana recognised and protected by the constitution of the country. According to 
the official reports, South Africa’s total land surface area is more than 1.2 Million km2, which 
represents 2% of the world’s land surface area. It houses 10% of the world’s plants, 7% of the 
world’s reptiles, birds and mammals, 15% of known coastal marine species, and one entire floral 
kingdom1）. As of 2009, there were 23,000 plant species and 65% of these are endemic to South 
Africa2）. The most biodiversity hotspot areas in South Africa are found in the Maputaland-
Pondoland-Albany, the Cape Floristic Region and the Succulent Karoo. In terms of the number of 
endemic species of mammals, birds, reptiles and amphibians, South Africa ranks the fifth richest 
country in Africa and the 24th in the world.
South Africa also has a long tradition of medicinal use of indigenous plant species. There is an 
estimated 500,000 Traditional Health Practitioners (THPs) in South Africa, found in the provinces 
of South Africa. The THPs play an important role in the health care delivery for the majority of the 
people of South Africa3）4）. The South African Traditional Health Practitioners Act of 2007, 
recognizes the THPs as part of the health care system. The Act defines a THP is someone who is 
registered under this Act at the South African Department of Health, to perform functions, 
activities, processes or services based on a traditional philosophy, which includes the utilisation of 
traditional medicine or traditional practice, as well as the physical or mental preparation of an 
 1）	 See: https://www.cbd.int/reports/search/?country=za
 2）	 ibid.
 3）	Zuma, T., Wight, D., Rochat, T. and Moshabela, M (2016). “The role of traditional health practitioners in Rural 
KwaZulu-Natal, South Africa: generic or mode specific?”, Complementary and Alternative Medicine, Volume 
16, pp.304-317
 4）	 Sorsdahl K, Stein DJ, Grimsrud A, et al. (2009) “Traditional healers in the treatment of common mental disorders 
in South Africa”, Journal of Nervous System and Mental Diseases, Volume 197, pp.434
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individual for puberty, adulthood, pregnancy, childbirth, and death5）. The Act includes herbalists 
(izinyanga or amaxhwele), diviners (izangoma or amagqirha), traditional surgeons (iingcibi) who 
mainly do circumcisions, and traditional birth attendants (ababelethisi or abazalisi) under the THP 
category. The THPs are, however, not institutionalised in South Africa into mainstream primary 
health care systems, due to lack of regulations for their practices including the traditional 
medicine formulations they administer to their patients, often the health claims are not supported 
by the scientific evidence.
Despite, about 80% of South Africans consult a THP for health care including cultural purposes. 
This mainly due to the fact that the THPs are integral members of the society and therefore easily 
accessible for consultations which are affordable compared to western form of consultations, and 
also THPs are part of traditional and cultural practices. About 3 000 plant species are used in 
traditional medicines by the THPs to treat human diseases. About 25% of prescription medicines 
and drugs worldwide have been developed from plant species that have TK6）.
The United Nations Conference on Environment and Development (UNCED) was introduced with 
the following three primary objectives7）: 1) conservation of biological diversity, 2) sustainable use 
of the components of biological diversity (such as plant genetic resources) and 3) the fair and 
equitable sharing of benefits arising from the utilisation of genetic resources recently. Because of 
the value of TK to drug development, for instance, the CBD translates its guiding objectives of 
conservation, sustainable use and equitable sharing of benefits into binding commitments in its 
articles to implement. There are currently 191 parties to the CBD including South Africa.
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of 
Benefits8） was adopted by the Conference of the Parties to the Convention on Biological Diversity 
on 29 October 2010 in Nagoya, to advance the third objective of the CBD and has been in 
enforcement since 12 October 2014, as two thirds majority countries have ratified the Protocol. 
South Africa ratified the Nagoya Protocol on 12 October 2014.
The realization that TK and associated biodiversity can stimulate R&D and innovation to 
commercialise valuable drugs, cosmetics and functional food products. On the other hand, 
 5）	 South African Traditional Health Practitioner Act, 2008
 6）	Yuan, H., Ma, Q., 1, Ye, L. & Guangchun Piao, G. (2016)” The Traditional Medicine and Modern Medicine 
from Natural Products”, Molecules, Volume 21, pp.1-18, see: www.mdpi.com/journal/molecules
 7）	Conservation on Biological Diversity, see https://www.cbd.int/convention/text/
 8）	Nagoya Protocol on Access and Benefit Sharing, 2010, see https://www.cbd.int/abs/
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accessing TK for R&D and commercialisation purposes of indigenous and local communities 
without their consent has led to concerns in recent years that protection of some kind is required 
to prevent abuse. The realization that TK and associated biodiversity can stimulate R&D and 
innovation to commercialise valuable drugs, cosmetics and functional food products. On the other 
hand, accessing TK for R&D and commercialisation purposes of indigenous and local communities 
without their consent has led to concerns in recent years that protection of some kind is required 
to prevent abuse.
South Africa has amended several of its intellectual property right laws, to align to the provisions 
of the CBD and the Nagoya Protocol on Access and Benefit Sharing, to prevent unauthorised 
access to TK and unsustainable use of indigenous biological resources, to the legislative protection 
and commercialization of TK.
In order to provide an understanding of the protection and commercialization of TK and 
indigenous biological resources from the South African context, this paper begins by describing 
the South African intellectual property rights (IPRs) systems, amendment to and introduction of 
certain laws to strengthen the protection of TK, and linkages of these laws with the access and 
benefit sharing (ABS) legislations. The paper then demonstrates the application of these laws in 
practice, through the Council for Scientific and Industrial Research (CSIR) case studies. This paper 
concludes that South Africa has a comprehensive legal framework for the protection of TK, to 
prevent the illegal access of TK and indigenous biological resource for research and development 
(R&D) and commercial purposes. CSIR has been the leading institution on the African continent in 
managing to translate TK and R&D into technologies and products of commercial potential and 
recognising the TK holders in benefit sharing agreements and conserving biological diversity 
through the agroprocessing community businesses, as part of poverty alleviation and job creation. 
The CSIR experiences are shared with Japan, in order to begin conversations to develop ties 
between the two countries on natural products for mutual benefit. Japan ratified the Nagoya 
Protocol on 22 May 2017, and the Guidelines on ABS went into effect on 20 August 2017, to 
ensure ABS practice by business and universities in accordance with the Nagoya Protocol on ABS 
principles. This in turn increases a body of knowledge that is made available for research.
2. The South African intellectual property right laws
2.1 The South African IP and TK protection laws
The South African Constitution is the supreme law of South Africa, which provides the legal 
foundation for the protection of intellectual property rights (IPR) from arbitrary deprivation and in 
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recent decades, South Africa has made significant strides in the just protection, administration, 
management, and deployment of intellectual property9）. The National Development Plan of South 
Africa calls for a greater emphasis on innovation, improved productivity, an intensive pursuit of a 
knowledge economy and the better exploitation of comparative and competitive advantages10）. 
Intellectual Property is an important policy instrument in promoting innovation, technology 
transfer, research and development (R&D), creative expression, consumer protection, industrial 
development and more broadly, economic growth, to address national issues of poverty, 
unemployment and inequality. There is an empirical evidence to confirm that intellectual property 
rights has a positive impact on developing countries innovations and competiveness and 
subsequently socioeconomic development.11）
South Africa has a comprehensive laws for the protection of IP and TK, to protect people’s rights 
to own their creative products and such protection extends from an idea, a name or an invention 
(Table 1). The legal definition of intellectual property is broad and inclusive of creations of the 
mind, inventions; literary and artistic works; and symbols, names and images used in commerce. 
An intangible right protecting the products of human intelligence and creation, such as 
copyrightable works, trademarks and trade secrets.
Table 1:  The South African IP and TK protection laws and the associated government Departments
Laws (legislation/policy) Responsible government
・	Intellectual Property Laws Amendment Act 2013 (Act No. 
28 of 2013) 
Department of Trade and Industry
・	Intellectual Property Rights from Publicly Financed 
Research and Development Act 2008 (Act No. 51 of 2008) 
Department of Science and Technology
・	Traditional Health Practitioners Act 2008 (Act No 30660 of 
2008)
・	Patents Amendment Act 2005 (Act No. 20 of 2005) Department of Trade and Industry
・	Patents Act 1978 (Act No. 57 of 1978, as amended up to 
Patents Amendment Act 2002)
Department of Trade and Industry
・	Merchandise Marks Act 1941 (Act No. 17 of 1941, as 
amended up to Merchandise Marks Amendment Act 
2002) 
Department of Trade and Industry
・	Performers’ Protection Amendment Act 2002 Department of Trade and Industry
 9）	The Constitution of the Republic of South Africa (as adopted on 8 May 1996 and emended amended on 11 
October 1996 by the Constitutional Assembly), The Government of South Africa, Pretoria
10）	 “The National Development Plan: Vision 2030”, Government of South Africa, Pretoria, South Africa
11）	Yongmin Chen and Thitima Puttitanum (2005),” Intellectual property rights and innovation in developing 
countries”, Journal of Development Economics Volume 78, pp.474-493
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・	Copyright Act, 1978 (Act No. 98 of 1978, as amended up to 
Copyright Amendment Act 2002)
Department of Trade and Industry
・	Intellectual Property Laws Amendment Act 1997 (Act No. 
38 of 1997)
Department of Trade and Industry
・	Designs Act 1993 (Act No. 195 of 1993, as amended by 
Intellectual Property Laws Amendment Act 1997)
Department of Trade and Industry
・	Plant Breeders' Rights Amendment Act 1996 (Act No. 673 
of 1996)
Department of Trade and Industry
・	Plant Breeders’ Rights Act 1976 (Act No. 15 of 1976, as last 
amended by Plant Breeders’ Rights Amendment Act 1996) 
Department of Trade and Industry
・	Indigenous Knowledge Systems Policy, 2004 Department of Science and Technology
・	Trade Marks Act 1993 (Act No. 194 of 1993) Department of Trade and Industry
・	Indigenous Knowledge Systems Bill, 2016 Department of Science and Technology
The DTI (Department of Trade and Industry) is the custodian of intellectual property rights South 
Africa. It provides an enabling legislation and services required for the registration, examination 
(in the case of trademarks), and adjudication of intellectual property. However, the related 
legislations to intellectual property can originate or involve participation from a number of 
government departments and statutory bodies, such as the Departments’ of Arts and Culture, 
Science and Technology, Health, Communications, Environmental Affairs, Agriculture: and 
Education, as well as statutory bodies such as the National Advisory Council on Innovation and 
the Council for Scientific and Industrial Research(CSIR)12）. New legislation regarding genetically 
modified foods, for instance, requires an assessment of the agricultural, health, environmental and 
industrial policy aspects, thus requiring careful policy coordination, balancing potentially 
conflicting policy goals.
The South African intellectual property laws are in line with provisions of the various international 
agreements and conventions, including the World Trade Organisation Agreement on Trade Related 
Aspects of Intellectual Property Rights (TRIPS) and Patent Cooperation Treaty (PCT). Therefore, 
South Africa is obliged to comply with the minimum standards set by these agreements for the 
protection of intellectual property. The standards define the scope of the inventor’s exclusive 
rights, the limitations set the boundaries of those rights (e.g. by allowing compulsory licensing) 
and the administrative and judicial enforcement determine the effectiveness of the intellectual 
property rights regime. All three elements vary widely across countries, even among developed 
countries. South Africa is not party to ARIPO (African Regional Intellectual Property Organisation) 
and has developed a comprehensive intellectual property right protection laws that are in line with 
12）	Ethèl Teljeur (2003), “Intellectual Property Rights in South Africa”, The Edge Institute, South Africa
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the provisions of the WTO TRIPS.
The South African intellectual property laws have certain limitations when applied to traditional 
knowledge. For instance, the South African Patent Act of 1978 makes it difficult to protect 
traditional knowledge, due to the nature of the knowledge, which is in the public domain and also 
is community owned. Therefore, there is a need for a suitable law to protect traditional knowledge 
to strengthen socioeconomic benefit.
2.2 Patent Act, 1978
South Africa adopted the Patent legislation, hereto referred to as Patent Act, 1978, to “provide for 
the registration and granting of patents for inventions and for matters connected therewith”13）. The 
legislation states that a patent may be granted for any new invention which involves an inventive 
step and which is capable of being used or applied in trade or industry or agriculture. Therefore, 
a patent is a negative right, awarding inventors the exclusive right “to prevent others from 
making, selling, distributing, importing or using their invention, without licence or authorisation, 
for a fixed period of time”. Technological innovations are protected through a patent, even those 
informed by traditional knowledge and associated by biodiversity.
A patent generally consists of a document issued by the government that describes an invention 
(product or process) and creates exclusive rights for a limited period in which the patented 
invention can only be exploited with the authorisation of the patent holder and in exchange for 
licensing or royalty payments. The minimum requirement for the protection of the intellectual 
property according to the legislation is 20 years, from the date of application14）. This is in line with 
the WTO TRIPS Agreement, which stipulates a 20 years minimum protection from filing date. The 
legislation provides an annual renewal obligation of a patent with costs. No extension is possible. 
Patents are awarded to the first applicant; this so-called ‘first-to-file’ rule is nearly universal, with 
the main exception being the US, which uses the ‘first-to-invent’ rule.
2.3  Intellectual Property Rights from Publicly Financed Research and Development 
Act, 2008
The South African government promulgated the Intellectual Property Rights from Publicly 
Financed Research and Development Act on 22 December 2008 and the objective of the law is “to 
provide for more effective utilisation of intellectual property emanating from publicly financed 
13）	 South African Patent Act, No. 57, 1978
14）	 South African Patent Act, 1978, Section 46(1)
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research and development”15）. This means that the law has been adopted with the intention to 
enhance the production of patents from research and technological activities undertaken by the 
South African research institutions including universities through public funds and ensuring that 
such intellectual property benefits the socioeconomic development of South Africa, including 
capacity development, technology transfer, job creation, enterprise development, social upliftment 
and products, or processes or services that embody or use the intellectual property16）. Therefore, 
the law seeks to address the situation where the intellectual property developed by the research 
institutions benefits the research institution, the government or South African people17）.
The Intellectual Property Rights from Publicly Financed Research and Development Act, 2008 
defines intellectual property as “any creation of the mind that is capable of being protected by law... 
any rights in such creation... but excludes copyrighted works... in the ordinary course of business, is 
associated with conventional academic work”. In this case, intellectual property will includes 
inventions, designs, etc. and excludes copyrighted works such as thesis, articles, handbooks or any 
other publications18）. However, if there is an invention which is the subject of the thesis or an 
article, such invention will be subject to the law. A trademark associated with commercialization of 
a particular invention is also the subject of the law. Publicly financed research and development, in 
terms of the law, refers to research and development undertaken using any funds allocated by a 
funding agency (i.e. state, a state agency or an organ of state) but excludes funds allocated for 
scholarships to be publicly financed research and development and the provisions of the law shall 
not have any impact thereto. Therefore, the parties can negotiate with regard to ownership of such 
intellectual property. For example, the private entity can then negotiate that it retains ownership of 
such intellectual property.
Under certain conditions, the law make provides the ownership of the intellectual property by a 
privately owned company or institution or may become a co-owner of the intellectual property 
emanating from publicly financed R&D undertaken at an institution. There conditions are:
	 ◦ 	there has been a contribution of resources, which may include relevant background 
intellectual property, or other resources by the private entity or organisation; and
15）	The Intellectual Property Rights from Publicly Financed Research and Development Act, 2008
16）	Regulations in terms of section 17 of the Intellectual Property Rights from Publicly Financed Research and 
Development Act, 2008 (Act No. 51 of 2008)
17）	Bansi, R, & Reddy, K. (2015), “Intellectual property from publicly financed research and intellectual property 
registration by universities: A case study of a university in South Africa”, Procedia - Social and Behavioural 
Sciences Volume 181, pp.185-196
18）	Adams & Adams: patent, trademark, copyright, commercial, property and litigation attorneys (2013)
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	 ◦ there is joint intellectual property creatorship; and
	 ◦ 	appropriate arrangements are made for benefit sharing for intellectual property creators at 
the institution;
 ◦ 	the institution and the private entity or organisation conclude an agreement for the 
commercialisation of the intellectual property.
However, the law does not apply when the private company or institution has funded the research 
and development by the university on a full cost basis. “Full cost” means the full cost of 
undertaking the R&D as determined in accordance with international financial reporting 
standards, and includes all applicable direct and indirect costs as may be prescribed. The indirect 
costs can include operational costs, costs relating to raw material, the use of laboratory, the use of 
electricity and water in the laboratory, and the costs associated with the time that each member of 
a research team of the institution spends conducting the research and development. Therefore, 
both the private company and the university can negotiate with regard to ownership of such 
intellectual property. For example, the private entity can then negotiate that it retains ownership of 
such intellectual property.
The Intellectual Property Rights from Publicly Financed Research and Development Act 
established the National Intellectual Property Management Office, as well as the Intellectual 
Property and Technology Transfer Offices at South African universities. There are more than 14 
Technology Transfer Offices established at publicly funded research institutions including 
universities, with well-defined organisational structures, technology transfer systems and 
practices19）. The law, administered by the Department of Science and Technology, including 
provision of funding for implementation including capacity building through the National 
Intellectual Property Management Office.
3  South African legislation and policy: TK and biodiversity protection
3.1 Indigenous Knowledge Systems Policy, 2004
The IKS Policy was approved by the South African government in November 2004, to create a 
platform to recognize, affirm, develop, promote and protect IKS which includes TK in South 
Africa; and to interface IKS with other knowledge systems, such as scientific and technological 
knowledge especially in the modern biotechnology and pharmaceutical sectors to increase the rate 
19）	Alessandrini, M., Klose, K. and Pepper, M (2016) “University Entrepreneurship in South Africa: Developments 
in Technology Transfer Practices”, Institute for Cellular and Molecular Medicine, University of Pretoria, South 
Africa, University of Pretoria, South Africa.
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of innovation, through active participation of the local communities in the research and innovation 
processes20）. The Department of Science and Technology is the custodian of the Policy, which 
provides management and administrative leadership including funding for the implementation of 
the Policy, through the National Indigenous Knowledge Systems Office (NIKSO) within the 
Departments. NIKSO has three Directorates: Advocacy and Policy Development, Knowledge 
Development and Knowledge Management.
The IKS Policy was adopted after extensive consultations with the academic institutions and a wide 
range of stakeholders in business, NGOs and Traditional Health Practitioners Associations who 
reflected, debated and participated to reflect the aspirations of the country in socioeconomic 
development. One of the areas of action identified by the Policy is the protection of TK, and the 
recognition of the TK Holders in benefit sharing agreements and other knowledge production 
outputs, such as publications. According to the Policy, protection of TK includes ensuring TK 
Holders receive a fair and sustained recognition and, where appropriate, financial remuneration for 
the use of this knowledge.
The main drivers of the IKS Policy in developing the innovation capacity in the South African 
system of innovation include, among others: towards the recognition and protection of IK Holders 
include: 1) Affirmation of African cultural values in the face of globalisation imperative given the 
need to promote a positive African identity; 2) Practical measures for the development of services 
provided by the TK Holders including the THPs, with a particular focus on traditional medicine, 
but also including areas such as agriculture, indigenous languages and folklore; 3) Underpinning 
the contribution of indigenous knowledge to the economy – the role of TK in job and wealth 
creation and poverty alleviation; and 4) interfaces with other knowledge systems, for example 
indigenous knowledge is used together with modern biotechnology in the pharmaceutical and 
other sectors to increase the rate of innovation.
The main implementation drivers of the IKS Policy, through the functions, institutions and 
legislative provisions are:
	 ◦ 	An Advisory Committee on indigenous knowledge systems, reporting to the Minister of 
Science and Technology;
 ◦ 	A development function; including, academic and applied research, development and 
innovation in respect of IKS;
 ◦ 	National Recordal System for indigenous knowledge and indigenous knowledge holders; 
20）	 Indigenous Knowledge Systems Policy, 2004
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where appropriate, to pro-actively secure their legal rights;
 ◦ 	The promotion of networking structures among practitioners, to be located in the Department 
of Science and Technology; and
 ◦ 	Legislation to protect intellectual property associated with indigenous knowledge, to be 
administered by the Department of Trade and Industry
This policy document became the key document for IKS in South Africa and has been funded by 
the Department of Science and Technology National Indigenous Knowledge Systems Office. The 
key achievements of the policy are outlined in Table 2.
Table 2: The achievements of the IKS Policy, 2004 to date
◦ 	Education and training: IKS Bachelor degree programme established at the University of KwaZulu Natal, 
South Africa and University of North West-Mahikeng Campus, funded by the Department of Science 
and Technology National Indigenous Knowledge Systems Office
◦ 	IKS Research Chairs, to interface IKS with other knowledge systems with a special emphasis on scientific 
and technological knowledge. The IKS Research Chairs are managed by the National Research 
Foundation on behalf of the Department of Science and Technology. Two Research chairs on IKS have 
been established: 1) University of KwaZulu Natal (four projects - HIV and AIDS, Tuberculosis, 
Diabetes and Cancer); and 2) Walter Sisulu University (two projects – IKS Systematisation and 
Vegetable & medicinal plants)
◦ 	IKS Calls for funding proposals, aimed at enforcing collaborations between the local communities and 
research institutions on R&D projects. The Call is management by the National Research Foundation 
on behalf of the Department of Science and Technology NIKSO. IKS Ring fenced funding for IKS 
research is annually transferred to the National Research Foundation. Following the IKS Fund review, 
IKS Programme piloted and implemented the New Research Management System as an IKS Policy 
imperative. About eight Calls have been published by the National Research Foundation since 2012.
◦ 	Documentation of IKS (e.g. National Recordal System), to provide both positive and defensive protection 
of TK. The system constitute a semantic web digital system, comprising of TK networks, 
documentation centres and confidential local registers and records unrecorded TK in various 
multimedia and aims to collect grassroots community TK and experiences in local languages. The 
National Recordal System is a documented data on TK and associated biological resources linked to a 
person, community, geographical area and biological resource. About 56 communities participated in 
the establishment of the National Recordal System.
◦ 	IKS expo’s in South Africa and internationally, aimed to disseminate information targeted at audiences 
to enhance public understanding of the South African IKS. About 5 National IKS Expo’s held, IKS part 
of National Science Week, 5 SADC Biennial Workshops International Conference: Value of IKS in 21st 
Century
◦ 	Digital database (pharmacopoeia) was developed to give access to 1536 open access journals, 269 South 
African theses, 32 digitised books, 185 updated monographs including conference papers.
The IKS Policy is relevant to other government policies and legislations and has been an advocate 
for the amendment of the IPRs laws to protect IKS promote access and benefit sharing.
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3.2 Biodiversity Act, 2004 and its BABS Regulations, 2008
The South African government, through the Department of Environmental Affairs, adopted the 
National Environmental Management: Biodiversity Act, 2004 and the Bioprospecting, Access and 
Benefit Sharing Amendment Regulations of 2015. The objectives of the Act include, among others 
measures, conservation of South Africa’s biodiversity within the framework of the National 
Environmental Management Act, 1998, the sustainable use of indigenous biological resources and 
the fair and equitable sharing of benefits arising from bioprospecting involving indigenous 
biological resources21）. Indigenous biological resources, in terms of the Act, include: any animals, 
plants or other organisms of an indigenous species cultivated, bred or kept in captivity or 
cultivated or altered in any way by means of biotechnology; any cultivar, variety, strain, derivative, 
hybrid or fertile version of any indigenous species or of any animals, plants or other organisms; 
any exotic animals, plants or other organisms, whether gathered from the wild or accessed from 
any other source which, through the use of biotechnology, have been altered with any genetic 
material or chemical compound found in any indigenous species or any animals, plants or other 
organisms22）. The Act excludes (i) genetic material of human origin, (ii) any exotic animals, plants 
or other organisms, other than exotic animals, (iii) indigenous biological resources listed in terms 
of the International Treaty, (iii) Plant Genetic Resources for Food and Agriculture.
The Act also seeks to give effect to the ratified international agreements relating to biodiversity 
which are binding on the Republic, such as the Convention on Biological Diversity, 1993 and its 
two protocols, i.e., the Cartagena Protocol on Biosafety and the Nagoya Protocol on Access and 
Benefit Sharing. The Biodiversity Act regulates bioprospecting involving indigenous biological 
resources and the export from the Republic of indigenous biological resources for the purpose of 
bioprospecting or any other kind of research. The Act also provides for a fair and equitable 
sharing by stakeholders in benefits arising from bioprospecting involving indigenous biological 
resources.
The Nagoya Protocol on Access and Benefit Sharing provides a legal framework for the effective 
implementation of one of the three objectives of the Convention on Biological Diversity, namely, 
the fair and equitable sharing of benefits arising out of the utilization of genetic resources and 
traditional knowledge associated with genetic resources. Furthermore, the Nagoya Protocol on 
Access and Benefit Sharing represents an important tool for greater legal certainty and 
transparency for both providers and users of genetic resources, and for strengthening the ability 
21）	National Environmental: Biodiversity Act, 2004, Government of South Africa, Pretoria,
22）	Chapter 6 (Section 8(2): Bioprospecting, Access and Benefit Sharing), Biodiversity Act, 2004
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of indigenous and local communities to benefit from the use of their traditional knowledge, 
innovations, and practices associated with genetic resources. The Nagoya Protocol on Access and 
Benefit Sharing came into force on 12 October 2014 and South Africa ratified the Protocol in 
October 2014.
The South African Biodiversity Act, 2004 establishes the National Bioprospecting Trust Fund 
(Section 85(1)), to administer all the milestones and royalty payments received from the 
bioprospecting permit holders in terms of the benefit sharing agreements and material transfer 
agreements and disburse to the funds to the rightful owners of the traditional knowledge that 
informed the bioprospecting project. The Director General of the Department of Environmental 
Affairs manages the Fund and accountable for the money in the Fund in terms of the Act23）, in 
terms of the Public Finance Management Act24）
3.3 Patent Amendment Act, 2005
The South African Patent Act of 1978 was amended in 2005, to give to Patent Amendment Act, 
2005. The Patent Amendment Act requires an applicant for a patent to furnish information relating 
to any role played by an indigenous biological resource, a genetic resource or traditional 
knowledge”25）. This is to ensure that indigenous communities are adequately compensated when 
an invention which is sought to be patented in South Africa is derived from indigenous biological 
resource and associated traditional knowledge from South Africa.
Consequently, the Patents Amendment Act, 2005 requires that every applicant who lodges an 
application for a patent must state whether or not the claimed invention is:
 ◦  based on or derived from an indigenous biological resource or an indigenous genetic 
resource; and/or
 ◦ based on or derived from traditional knowledge or use from South Africa.
Every applicant is required to lodge a statement of this type, irrespective of the nature of the 
invention sought to be protected, and it will not be possible to obtain a patent if the required 
statement is not lodged at the patent office. In addition, the Patents Amendment Act also provides 
a ground of revocation of a patent in cases where the required statement lodged by the applicant 
is false.
23）	Biodiversity Act, 2004 (Section 85 (3 a&b))
24）	Public Finance Management Act, 1999 (chapter 5, Section 39)
25）	Patent Amendment Act, 2007
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It should be noted that the required statement relates to indigenous (i.e. South African) resources 
and knowledge only. In other words, the required statement does not refer to biological or genetic 
resources or traditional knowledge from countries other than South Africa. It should also be noted 
that although still indigenous, the genetic resources to which the amendments to the Patents Act 
relate are broader than the indigenous biological resources defined in the Biodiversity Act, and in 
particular the amendments to the Patents Act do not have the exceptions that are included in the 
Biodiversity Act.
If an applicant acknowledges that the invention is based on or derived from an indigenous 
biological or genetic resource, or traditional knowledge, they will also have to submit proof of their 
title or authority to make use of the resource or traditional knowledge. In most instances, it is 
likely that this title or authority would need to be a permit issued in terms of Chapters 6 and 7 of 
the Biodiversity Act. Where, however, the resource is human genetic material or one of the other 
excluded sources defined in the Biodiversity Act, then it will obviously not be possible to obtain a 
permit in terms of the Biodiversity Act and alternative proof of title or authority will be required. 
3.4 Intellectual Property Laws Amendment Act, 2013
The Intellectual Property Laws Amendment Act, 2013 deals with the amendment and “grafting” of 
TK to IPR Acts Laws (refer to Table 1) using an IP-based approach to the protection of IKS, to-
 ◦ 	consider the development dynamics of South Africa and improve how IP supports small 
institutions and vulnerable individuals in society, including in the domain of public health
 ◦ 	nurture and promote a culture of innovation, by enabling creators and inventors to reach 
their full potential and contribute towards improving the competitiveness of our industries
 ◦ promote South African arts and culture
 ◦ 	solidify South Africa’s various international obligations, such as the Convention on Biological 
Diversity (CBD) and the Nagoya Protocol on Access to Genetic Resources and the Fair and 
Equitable Sharing of Benefits Arising from their Utilisation (Nagoya Protocol on ABS), in 
the service of our genetic resources and traditional knowledge associated with genetic 
resources
The strategy employed in developing the Intellectual Property Amendment Act, 2013 included:
	 ◦ 	advancing a balanced and coordinated approach to IP that regulates IPRs in line with the 
South African Constitution
 ◦ introducing key policy reforms that account for the development dynamics of South Africa
 ◦ promoting innovation and a knowledge economy
 ◦ 	leveraging competitive and comparative advantages to advance the transformation of the 
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South African economy
The Act has amended four IPRs Acts namely the Performers’ Protection Act, the Copyright Act, 
the Designs Act, and the Trade Marks Act. In so doing, it provides for recognition and protection 
for, and creates, new IP forms (-so-called “Indigenous/Traditional IP”) from respectively 
indigenous performances, indigenous copyright works, indigenous designs, and indigenous 
trademarks. In addition, the Intellectual Property Amendment Act, 2013 creates new derivative IP 
forms, which are IP forms adapted from the original indigenous forms. The Act defines an 
indigenous term or expression throughout the Act as including indigenous cultural expressions or 
knowledge26）. This inclusion of TK with what in essence are indigenous cultural terms or 
expressions in Acts that do not in principle protect technology.
The Intellectual Property Amendment Act, 2013 provides that the Minister of Trade and Industry 
to establish a National Council for Indigenous Knowledge, among others, to advise the Minister 
and the Registrars of Patents, Copyright etc on the above and other relevant matters. Lastly the 
Act provides for the commercialization and licensing of TK in an attempt to provide income to 
indigenous communities from the marketing of their TK and indigenous cultural expressions.
The Act will come into operation on a date to be determined by the President by proclamation in 
the Gazette after the regulations have been approved for to the Act. The Department of Trade and 
Industry is the custodian of the Act, providing administrative leadership to the relevant 
government departments involved, such as Department of Science and Technology.
3.5 Indigenous Knowledge Systems Bill, 2016
The South African government, through the Department of Science and Technology, has 
developed the Indigenous Knowledge Systems (IKS) Bill, 2016. The Bill has been subjected under 
extensive public consultation to gather inputs and comments from other government departments, 
research institutions including the universities, private sector companies involved in 
bioprospecting research and commercial activities based on TK and associated indigenous 
biological resource and local and indigenous communities. The Bill is currently in government 
process to be approved into a law.
The IKS Bill follows the Intellectual Property Laws Amendment Act, 2013 that was signed into law 
in South Africa on 10 December 2013. Once, the Bill has been approved into a law, it will provide 
26）	 South African Intellectual Property Amendment Act, 2013
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“sui generis” protection, promotion, development and management of TK including the registration 
of TK, the establishment of the National Indigenous Knowledge Systems Office (“NIKSO”), and an 
Advisory Panel to advise NIKSO27）. The Bill defines indigenous knowledge as “tangible and 
intangible aspects of the whole body of knowledge that has been held, used, refined and 
transmitted by the indigenous communities collectively or as individual custodians of such 
knowledge as part of expressing their cultural identity and includes but is not limited to –
 a. knowledge of and management of biological resources and ecosystems;
 b. literary, performing and artistic works (arts and culture);
 c. all items of moveable cultural property;
 d. all items of immoveable cultural property;
 e.  indigenous institutions, philosophies, governance matters and languages;
 f.  scientific, technical and spiritual knowledge;
 g. indigenous environmental resources; and
 h. indigenous communities' heritage;
The IKS Bill provides for the Act to protect indigenous knowledge (IK), whether it is functional or 
cultural, or both, including medical, agricultural or scientific practices, as long as it complies with 
the eligibility criteria set out below. Such IK is regarded as being property as defined in section 25 
of the Constitution.
The eligibility criteria for protection applies to IK which – has been passed on from generation to 
generation within an indigenous community; has been developed within an indigenous community; 
and is associated with the cultural make-up and social identity of that indigenous community. The 
term of protection granted in respect of IK by this Act will last as long as the IK satisfies the 
above eligibility criteria for protection in terms of the new Act.
The exclusive rights conferred upon the holders of IK registrations are to: the benefits arising 
from its commercial use; be acknowledged as its source; and restrain any unauthorized use of the 
IK.
The functions and duties of NIKSO (which will be a non-juristic entity) include keeping a Register 
of IK, establishing a Registration Office, and the accreditation and certification of IK practitioners 
who may be recorded in the Register of Designations kept by NIKSO. NIKSO will also attend to 
27）	 South African Indigenous Knowledge Systems Bill, 2016
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registration of IK on behalf of an IK holder. A person seeking to obtain a copy of documents from 
the Register of IK must first enter into a non-disclosure agreement with NIKSO, as prescribed. In 
performing its functions, NIKSO must develop and implement an effective regulatory framework 
for the protection, promotion, development, management and education in respect of IK systems. 
NIKSO may, at the request of an indigenous community, provide assistance or facilitate the 
commercialization and use of its IK.
If the holder of IK cannot be identified and designated, NIKSO must act as custodian of that IK. A 
person wishing to acquire the right to use IK shall apply to NIKSO for a licence and shall enter 
into a benefit-sharing agreement with NIKSO. Any person who uses IK without authorization, or 
otherwise contravenes certain important provisions of this Act, shall be guilty of an offence and 
liable on conviction to imprisonment for a period not exceeding three years or to a fine of 
R30 000, or both.
IK originating in a foreign jurisdiction must be given the same protection given to IK originating 
in South Africa, provided that the laws of that foreign jurisdiction provide reciprocal protection to 
IK originating in South Africa. A sharing of ownership of IK is possible where IK originates in one 
or more foreign jurisdictions and in South Africa.
An IK holder wishing to register IK which existed prior to the commencement of the new Act, 
must register such IK within 12 months from the date of commencement of this Act.
4. Traditional knowledge and Biodiversity: CSIR case studies
This section describes the CSIR proprietary case studies based on the South African indigenous 
plant species and the related traditional knowledge, to support the value of traditional knowledge 
to scientific research, and demonstrate the beneficiation of local communities’ traditional 
knowledge and sustainable use and conservation of biodiversity.
A Consortium of eight Traditional Health Practitioners from South Africa approached CSIR during 
the early nineties in connection with a panel of the South African indigenous plant species, to 
investigate for their traditional uses. The Consortium represents the Traditional Health 
Practitioners constituencies in the different provinces of South Africa, except the Western Cape. 
CSIR entered into a benefit sharing agreement with the Consortium whereby royalties on sales of 
the products developed from the use of their traditional knowledge and associated biological 
diversity are paid. Several agreements were entered into to protect the traditional knowledge of the 
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Consortium, as Memorandum of Understanding and Heads of Agreement. Four of the South 
African indigenous plant species from the Consortium were subjected to scientific investigation for 
their traditional uses using public funds, namely Lippia javanica, Monsonia angustifolia, 
Siphonochilus aethiopicus and Elephantorrhiza elephantina. Another South African indigenous plant 
species, Schlerochiton ilicifolium is discussed - which is not part of the panel of the plant species 
brought to CSIR by the Traditional Health Practitioners’ Consortium.
4.1 CSIR (host of SANBio Network) Context
The CSIR is one of the several science councils in South Africa which are responsible for scientific 
and technology research, development and implementation. South Africa’s CSIR was established in 
1945 as a science council by an Act of Parliament. It is a parastatal that is required to contribute to 
R&D in South Africa by undertaking integrated, multidisciplinary research across diverse areas of 
science.
The detailed mandate of the CSIR is set out in the Scientific Research Council Act, (Act 46 of 
1988, as amended by Act 71 of 1990), section 3 as follows:
“The objects of the CSIR are, through directed and particularly multidisciplinary research and 
technological innovation, to foster, in the national interest and in the fields which in its opinion should 
receive preference, industrial and scientific development, either by itself or in co-operation with principals 
from private or public sectors, and thereby to contribute to the improvement of the quality of life of the 
people of the Republic, and to perform any other functions that may be assigned to the CSIR by or under 
this act.”
The CSIR works closely, either as a partner or a client, with tertiary educational institutions, other 
science councils, research institutions and a range of private sector organizations’ locally and 
abroad. According to internal corporate documents, the CSIR places a focus on quality science and 
skills development for socio-economic impacts.
The CSIR owns and/or manages a number of specialist facilities of national importance. These 
include centers for laser technology, satellite applications, nano-structured materials, high-
performance computing, notational analysis of sports performance, coastal engineering and other 
modelling facilities, as well as testing facilities for wind resistance, mine hoist equipment, 
environmental samples and more. CSIR receives an annual grant from the Parliament through the 
Department of Science and Technology (DST), which accounts for some 40% of its total income. 
This is invested in knowledge generation, scientific infrastructure and enhancing skills. The CSIR’s 
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total operating income is more than R1 billion per annum. Income generated from contract 
research for public and private sector clients, locally and abroad, as well as from royalties, licenses 
and dividends from intellectual property management and commercial companies created by the 
CSIR is added to the income directly from government. CSIR earns in excess of R30 million in 
royalties per annum and also earns fees from consulting and analytical services that range from 
project management and fieldwork, and specialist testing.
CSIR has a dedicated unit for enterprise creation to facilitate the implementation of community-
owned, technology-based businesses that generate innovative products and employment 
opportunities. CSIR has a staff complement of around 2,300, of which close to two thirds are 
science, engineering and technology (SET) specialists; of these 50% are qualified at Master’s level 
and higher. CSIR invests in human capital development through under and postgraduate bursaries, 
internships and a range of training interventions to foster young talent and further develop 
expertise.
In 2005, the CSIR was selected by the New Partnership for Africa’s Development to host the 
SANBio Network for Biosciences. SANBio operates with a multi-country; regional approach and it 
consists of a regional hub (SANBio Hub at the CSIR) and a number of national nodes. A Hub is an 
institution that is involved in cutting edge research, has state-of-the art research facilities and 
human resources that is actively involved in research and development while Nodes are 
institutions that are also actively involved in research and have expertise that provide unique skills 
and research facilities to complement the capacity of the Hub28）. The SANBio Hub which has been 
designed to support the SANBio Network, aims to create the CSIR footprint in the SADC region 
and Africa as a whole, by providing, among others, access to work-class research and translational 
infrastructure and expertise in multidisciplinary and diverse scientific fields and capacity building.
Through the SANBio Hub, the Southern African region can leverage the extensive experience and 
world-class facilities at the CSIR to accelerate technology development coupled to human capital 
development. Furthermore, the Hub can facilitate access to other competencies within the CSIR 
(such as ICT, logistics, materials manufacture, resource monitoring and build environment 
planning) to facilitate the implementation of innovation programs to realize maximum societal 
impact in reasonable time frames.
28）	Africa’s Science and Technology Consolidated Plan of Action (2005), “New Partnership for Africa’s 
Development”, NEPAD Agency, Johannesburg, South Africa
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4.2 CSIR case studies on TK and ABS
4.2.1 Lippia javanica
The South African local communities based in rural areas have traditionally utilised Lippia 
javanica, commonly known as musukudi in Sepedi, as a mosquito repellent. The community cut 
branches of this plant species to wipe on the skin and around the entrances to dwellings at night 
or the branches are thrown on an open fire at night. The Traditional Healers’ Committee 
approached the CSIR regarding the traditional use of the plant. The traditional knowledge 
stimulated scientific research by the CSIR. The scientific research included identification of the 
chemotype of the Lippia javanica species with superior mosquito repellency properties, extraction 
of the essential oil from the plant using CSIR customized processes and chemical profiling and 
characterization of the essential oil using GC-MS (gas chromatography mass spectrometry).
The CSIR entered into a benefit sharing agreement with the Traditional Healer’s Committee in 
2003, with 6% royalty negotiated, for the role played of their traditional knowledge in scientific 
research, technology development and commercialisation. The CSIR filed a South African patent 
(PCT1/20141021/COB/CSIR/77) on the use of extracts and chemical compound identified in the 
plant as mosquito repellents and CSIR became the owner of the invention. According to the South 
African Patent Act of 1978, any person or institution who or that have discovered something and 
made a invention on it is the owner of the intellectual property, hence CSIR has the rights on the 
ownership of the intellectual property derived from the Lippia javanica plant. In August 2013, CSIR 
obtained the bioprospecting permit (BP 0006) to develop and commercialise products, as well as 
to cultivate the Lippia javanica for commercial purposes.
The CSIR licensed the intellectual property to a local entrepreneur to manufacture, market and 
distribute the mosquito repellent candles (Figure 1). The candle is being marketed under the 
“Fever-Tree” brand by the local entrepreneur29）.
29）	http://www.fever-tree.co.za/products.php
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Figure 1:  Mosquito repellent candles containing the Lippia javanica especial oil based on the CSIR 
technology
Source: Author 1
In 2005, CSIR, through funding from the Department of Science and Technology’ Socioeconomic 
Innovation Partnerships Programme, transferred the Lippia javanica technology to a local 
community in Giyani, Limpopo province for the establishment of a community owned business, 
called Hi-Hanyile, to cultivate, distil and extract the oil from commercial production of mosquito 
repellent candles (Figure 2).
Figure 2:  Commercial cultivation of Lippia javanica in Giyani, Limpopo through funding from the 
Department of Science and Technology,
Source: CSIR
The Hi-Hanyile community-owned business has been managed by the CSIR’ Enterprise Creation 
and Development Unit since 2005, to provide administrative support (i.e. financial, human 
resources and legal management).
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Between 2015 and 2017, the business has produced a total of 166.33 kg essential oil of Lippia 
javanica for the manufacture of the mosquito repellent candles, resulting in the creation of total 61 
jobs (both full time and part time) from the community of Giyani in Limpopo province. The 
employees are responsible for plant cultivation and harvesting and oil distillation. An experienced 
commercial farmer, through the facilitation of the CSIR, provided training to the community 
workers to implement the activities of agricultural and processing relating to Lippia javanica 
business, such as crop propagation from seed, crops establishment and planting, crop 
maintenance practices (such as irrigation, fertiliser application and weed-control), harvesting 
practices and processing through distillation for Lippia javanica oil production. About 46 576 
candles have been sold on the South African market by the commercial partner under “Fever 
Tree” brand between 2015 and 2017. The Hi-Hanyile community owned business is
In terms of the requirements of the Biodiversity Act, 2004 and the Benefit Sharing Agreement of 
6% between the CSIR and the Traditional Healers Committee, three monitory benefits were made 
to the Traditional Healers Committee via the National Bioprospecting Trust Fund, generated from 
the commercialisation of the Fever Tree mosquito repellent candles, have been made thus far.
In summary, the case study demonstrated the intrinsic value of traditional knowledge shared by 
the Traditional Healer’s Committee with CSIR to the CSIR to scientific research which led to the 
identification of the chemotype of the Lippia javanica species with superior mosquito repellency 
properties through government funding from the Department of Science and Technology, and to 
innovation (R&D linked to business and traditional knowledge holders collaboration with 
researchers and business) based on biodiversity, by applying the Patent Act, 1978, Patent 
Amendment Act, 2003 and Biodiversity Act, 2004 and its Chapter 6 of the Amended 
Bioprospecting, Access and Benefit Sharing Regulations, 2008 to intellectual property protection 
and management. The intellectual property relating to the chemical compound identified in the 
essential oil of Lippia javanica is owned by the CSIR. The CSIR is holding the bioprospecting 
permit on Lippia javanica to develop and commercialise products.
The community owned business in Giyani business based on Lippia javanica is a positive 
contribution to the efforts to ensure management of traditional knowledge and biodiversity 
conservation and a contribution to business, and to economic development of South Africa.
4.2.2 Schlerochiton ilicifolius
During the 1970s, CSIR went out of its way to search for plant species to develop into food 
technologies across South Africa and subsequently came across Sclerochiton ilicifolius, commonly 
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known as “molomo monate” in Limpopo province. According to the local communities of Limpopo 
province, it is believed that when eating the bark of the roots of “molomo monate” would make 
one words sweet. Figure 3A shows the local community member from Limpopo holding “molomo 
monate”, showing the roots of the plant species. The sweetness of the bark of the roots promoted 
the CSIR research and development, to investigate the properties of this indigenous plant species 
by extracting and characterizing a non-carbohydrate chemical compound sweetener, called 
Monatin (Figure 3B). CSIR discovered that Monatin was more than 1 400 times sweeter than the 
normal sugar although it is a non-nutritive sweetener.
Monatin is a naturally occurring, novel non-nutritive, high intensity sweetener originally isolated 
from the barks of the roots of the plant species Sclerochiton ilicifolius (Figure 3) .The CSIR first 
patent (1988 US Patent 4,975,298) was granted in 1988 and the various related patents (1991 US 
Patent 5,128,164, 2009 European Patent 2 090 173 A1) followed. CSIR obtained the bioprospecting 
permit (BAP0003) in 2012, which was one of the first such permits to be granted in South Africa, 
in terms of the Biodiversity Act, 2004.
Figure 3:  Root of the Sclerochiton ilicifolius (“molomo monate”) (A) and the Monatin compound 
isolated from the root of the plant species (B)
Source: Council for Scientific and Industrial Research
In May 2004, the CSIR, through its fully owned subsidiary, Technifin signed a “Monatin license 
agreement” with Cargill, a multinational company, based in the United States of America. Monatin 
is currently being developed as a non-nutritive sweetener and a rigorous program of safety studies 
is currently underway. The safety data on the monatin chemical compound has been produced and 
is being analysed and evaluated, to determine whether any additional studies may be required. 
The safety studies have been completed and submitted to the FDA for a review as part of the 
GRAS process. Monatin will not be extracted from the plant species Sclerochiton ilicifolius but will 
be produced through a novel enzymatic process.
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CSIR was supported by the National Departments’ of Environmental Affairs and Science and 
Technology and Limpopo Provincial Department of Tourism and Environment, to identify the 
communities associated with “molomo monate” and negotiate the benefit sharing agreements. The 
respective communities identified are Seleka and Shongoane communities and CSIR has 
respective benefit sharing agreements with the communities, which were approved by the South 
African Minister of Environmental Affairs in terms of the Biodiversity, Act, 2004.  A total of R 2.6 
Million as milestone payment was paid to these communities via the National Bioprospecting 
Trust Fund, in terms of the Biodiversity Act, 2004, used towards community upliftment projects.
In summary, this project is one of the promising benefit sharing agreement to make the biggest 
payment to the communities for their contribution with traditional knowledge to the CSIR 
research and development. The milestone payment is the biggest in the history of the South 
African ABS.
4.2.3 Monsonia angustofolia
Monsonia angustifolia is a member of the Geraniaceae family. It is perennial herb which bears pink 
flowers and whose geographic distribution is in open grassland throughout South Africa.
Figure 4: Monsonia angustifolia
South African National Biodiversity Institute
Monsonia is traditionally used for various diseases such as increasing male and female libido, 
diarrhoea, ophthalmia, haemorrhoids, stomach ulcer, indigestion and liver disorder. An aqueous 
and different organic extracts were prepared from the leaves and stems of the plant and 
chemically profiled. Four lignan compounds were isolated from the dichloromethane/methanol 
extract of the plant and biologically evaluated for their activity in Alzheimer’s disease assays. Both 
the plant extract and one of the lignan-type compounds isolated from the extract were found to 
actively inhibit the production of Aβ42 and Aβ40 in vitro.
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In 2014, CSIR applied two patents (US20140087008A1 and US20140088186A1) for “Composition for 
preventing or treating dementia comprising extracts of Monsonia species” and “Composition 
containing arylnaphthalene lignan derivative for preventing and/or treating dementia” respectively. 
CSIR signed the benefit sharing agreement with the Traditional Healers Committee in 2003 and 
the bioprospecting permit (BABS 000711P) issued by the Department of Environmental Affairs in 
terms of the Biodiversity Act, 2004, to develop and market products.
No products have been produced and commercialised. The CSIR is exploring potential commercial 
partners whom to license the technology from the plant species. No licensing agreement has been 
signed and no royalties collected.
4.2.4 Siphonochilus aethiopicus
The CSIR (through Biosciences Unit) interactions with the Traditional Healers Committee led to 
the identification of Siphonochilus aethiopicus, commonly known as African Ginger (Figure 5). It is 
one of the most widely used medicinal plants in South Africa, used traditionally for managing 
allergic diseases such as asthma, colds, influenza and sinus problems. Scientific research 
conducted, demonstrated the beneficial properties of the plant extract. The CSIR was granted a 
PCT patent for use of the extract and compound (PCT/IB2007/050649) and there is no private 
sector company involvement in terms of licensing agreement.
Figure 5: African Ginger
Source: South African National Biodiversity Institute
The CSIR is planning to undertake clinical studies on humans to investigate the anti-asthmatic and 
allergy properties of African Ginger through the Department of Environmental Affairs and UNDP 
GEF (United Nations Development Plan Global Environment Fund) and the proposal requesting 
funding for clinical studies has been submitted. There were no monetary (financial) benefits that 
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were paid to the Traditional Healers Committee in terms of Benefit Sharing Agreement of 2003. 
However, the Traditional Healers Committee was trained on agroprocessing, i.e. from extract 
preparation to making formulations (such as capsules, tea back and creams).
Based on the preclinical data and anecdotal use of the plant, process optimisation resulted in the 
development of a proprietary extraction method for African ginger. The most effective extraction 
method has been used by industrial partner Afriplex (a botanical manufacturing company) to 
conduct trial pilot-scale extractions leading to eventual commercial scale production. Afriplex’s key 
technology is the specialized extraction process that will result in a specific, active pharmaceutical 
ingredient (API) linked to specific therapeutic claims that will not be easily copied by a competitor. 
The API can be formulated into a range of products including cough mixtures, capsules, lozenges, 
decongestant rubs and hot tonics.
Highest levels of analytical quality control such as HPLC MS/MS have been used to show batch 
to batch reproducibility. The medicinal use of African Ginger is well known to the South African 
population and there is a high demand from the public for products based on this plant. Current 
products are mainly traded on the internet and are based on dried ground plant material.
A propagation programme for the plants from tissue-cultured material has been established by 
CSIR to prevent depletion of the plants in the wild and to ensure a reliable and sustainable supply 
of plant material for commercialization purposes (Figure 6).
Figure 6: Propagation Programme of African Ginger in KwaZulu Natal by CSIR
Source: CSIR
Community driven cultivation programmes have been established in collaboration with CSIR’s 
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Enterprise Creation for Development and the Agricultural Research Council and will have to be 
expanded to meet commercial demands for the raw material.
4.2.5 Elephantorrhiza elephantina
The CSIR received traditional knowledge information through its collaboration with the Traditional 
Health Practitioners Consortium on the use of Elephantorrhiza elephantina, to help relieve urinary 
pains, reduce the enlargement of the prostate and incontinence. This type of condition is called 
benign prostatic hyperplasia. Elephantorrhiza elephantina belongs to the Fabaceae family. Its 
common names are eland’s bean, elandswortel, elandsboontjie and intolwane30）.
Elephantorrhiza elephantina is one meter in height, growing from an enormous underground 
rhizome as a native weed (Figure 7). It is very invasive and a non-climbing, perennial shrub, 
which is not a threatened species. The branched root system often forms extensive colonies of 
visible plants. Seeds can be used to propagate this plant species31）. According to a farmer from the 
Limpopo province in South Africa, the plant species is traditionally used to treat diarrhoea, 
dysentery, stomach disorders, sexually transmitted diseases, haemorrhoids and perforated peptic 
ulcers. It is also used traditionally for promoting blood circulation, as an immune booster, 
treatment of urinary problems, and topically for treatment of skin problems and acne. The plants 
species is reported to be used for earaches, for treating diarrhoea in children, dysentery and 
sexual transmitted diseases32）. In Botswana, roots are used to clean wombs after an abortion and 
in Zimbabwe, roots are used for abdominal pain, infertility in women and as aphrodisiacs33）. This 
plant has also been proven scientifically to possess antimicrobial and antibacterial activity at the 
University of Botswana3. Traditionally, the rhizomes of this plant are prepared and drunk as a tea.
30）	 J.M. Watt, M.G. Breyer-Brandwijk, The medicinal and poisonous plants of Southern Africa, 2nd Edition, 
Edinburgh, 1962, pp. 596-597.
31）	H.P. Van der Schijff, L. Snyman, International Journal of Plant Sciences 1970, 76, pp. 114-128
32）	E. Aaku, M. Office, S.P. Dharani, R.R.T. Majinda, M.S. Motswaledi, Fitoterapia, 1998, 69, pp. 464-465.
33）	A. Hutchins, A.H. Scott, G. Lewis, A.B. Cunningham, Zulu Medicinal Plants. An inventory. University of Natal 
Press, Pietermaritzburg, 1996, p. 126.
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Figure 7: Elephantorrhiza Elephantina, leaves (A), underground rhizome (B) and sliced rhizomes (C)
Source: CSIR
Based on the assessment of a South African botanist, Elephantorrhiza elephantina is believed to be 
abundantly available in certain sites and this assessment was further supported by strong 
evidence published by scientists from the Department of Botany, University of Witwatersrand in 
Johannesburg, South Africa34）. The plant species is widely distributed in southern African countries 
such as Mozambique, Lesotho, South Africa, Swaziland, Zimbabwe, Botswana and Namibia35）.
On receiving this plant, an urologist based in Pretoria, South Africa evaluated the crude spray-
dried extract for benign prostatic hyperplasia and a verbal positive result was reported to CSIR. No 
published reports on the use of this plant as a treatment for benign prostatic hyperplasia were 
found.
A number of sites in different South African provinces were identified for the collection of this 
plant. The CSIR thus decided to attempt to investigate the medicinal properties of this plant, 
scientific research and development. The research included the identification of the correct plant 
species responsible for the reported activity and this was done in consultation with SANBI (South 
African National Biodiversity Institute). Literature searches were then conducted on the identified 
plant species, suitable extracts prepared and relevant in vitro and in vivo biological assays identified 
to investigate this claim.
A bioassay-guided fractionation was conducted to isolate and identify the biomarkers and active 
ingredient(s). Seven compounds were identified and investigated for in vitro inhibition of the 
steroid 5α-reductase enzyme. These compounds are being used as chemical markers to 
standardize the extract of Elephantorrhiza elephantina  for quality control purposes to show batch 
to batch reproducibility. Limited biological published information of these compounds led to their 
34）	W.N. Ellery, B.H. Walker, South African Journal of Botany. 1986, 52, pp. 100-104.
35）	 I. Hedberg, F. Staugard, Traditional medicine in Botswana. Traditional medicinal plants. Ipelegeng publishers, 
Gabarone, 1989 pp. 119-120.
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testing in vitro against other available biological targets. These compounds were therefore 
evaluated in vitro for different therapeutic applications such as anticancer, antimalarial, antioxidant 
and cytotoxicity.
Third party’s involvement in the project from South Africa prepared suitable formulations from 
Elaphantorrhiza elephantina such as shampoos and scalp massage serums. A three month stability 
study was conducted on Elephantorrhiza elephantina  and the formulations. The results showed 
good stability at room temperature, very low temperature (4oC) and higher temperatures (40oC 
and 50oC).
The formulations (scalp massage serum) were further tested for skin irritancy properties using 
patch testing on human test subjects. The formulation was shown to be non-irritants as they 
showed a decrease in irritancy potential relative to the negative control. The clinical safety 
assessment of Elephantorrhiza elephantina and other ingredients in the formulation was evaluated 
on a monolayer of rabbit cornea fibroblasts and was considered safe to use on humans.
Plans are underway to investigate the formulations developed from Elephantorrhiza elephantina for 
anti-hair loss properties on humans. Technology licensing agreement has been signed with a 
commercial partner for large scale manufacture of Elephantorrhiza elephantine extracts, marketing 
and selling. The CSIR has obtained the bioprospecting permit (BABS/000611P), to develop and 
market products.
Communities in the Northern Cape Province at Abbey and Avontuur have been identified to 
collect and supply Elephantorrhiza elephantina rhizomes. Field studies were conducted on methods 
of sustainable harvesting, propagation, management and commercialization of plant resources of 
Elephantorrhiza elephantina. The plant is very successful in its survival and proliferation. The 
community area has been fenced for land banking, and is a registered type locality for the specific 
chemo-type of Elephantorrhiza elephantina, which will act as a chemical reference standard. A 
community SMME is being established for harvesting and pre-processing of the plants.
The environmental impact assessment study was carried out by the CSIR Enterprise Creation for 
Development on Elephantorrhiza elephantine wild harvesting and found that the plant species has 
a high potential of in situ sustainable use. This high potential is largely due to the high abundance 
of the species and the fact that it has the potential to reproduce vegetatively. The CSIR obtained a 
harvesting permit from Northern Cape Provincial Department for harvesting 20 tonnes of the 
plant material per annum.
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No non-monetary benefits have been transferred as the final products will be evaluated in clinical 
studies on humans for anti-hair loss properties. No products have been produced and 
commercialised.
5. Conclusion
There is no doubt that South Africa is committed to the protection of TK, as well as value addition 
of TK and the associated indigenous biological resources. This is evident to the comprehensive 
legal framework and system on intellectual property and access and benefit sharing. For instance 
the Patent Act, 1978 was amended, herein referred to as Patent Amendment Act, 2005, to allow the 
protection of TK through ABS contacts and ensuring that the TK Holders become part of the 
benefit sharing recipients and are part of the value chain for the development of the South African 
Bio-economy and sustainable use of indigenous biological resources. This complement the 
provisions provided for in the Biodiversity Act, 2004 legislation on access and benefit sharing.
The government of South Africa is working on making some improvement in these laws to make 
it necessary for research institutions like CSIR, private sector companies and local and indigenous 
communities in order to deal with some complex issues of TK protection measures during 
technology development and commercialisation. The South African Bio-economy Strategy of 
201436） and the Bio-diversity economy Strategy37） support the development of TK into technologies 
and products of market value. These strategies capitalises on the unique biodiversity and TK that 
is found in the country, to develop technologies, products and industries that will help the country 
strengthen its GDP growth. For instance, the Bio-economy Strategy put an emphases on 
agriculture, health and industry as pillars to develop the bio-economy sector, by promoting 
industry-science-local communities-government linkages to work closely to each other, to ensure 
that technologies and products are market relevant and find easier application in South Africa. The 
Bio-diversity economy Strategy has identified the bioprospecting and wildlife sectors, promote 
linkages between these industries, research institutions and local communities based on 
indigenous biological resources to develop products of economic benefit to the country.
The CSIR, one of the largest research and technology development for industrialisation institution 
government owned institutions in South Africa, supports these government Strategic intents and 
the National Development Plan: Vision 2030, and has been at the forefront of adding value to TK 
36）	The	National	Biodiversity	Strategy	of	South	Africa,	2014
37）	The National Bio-diversity Economy Strategy, 2015
― 93―
and associated indigenous biological resource through scientific innovation and community owned 
agroprocessing businesses, while ensuring that the TK Holders benefit in the process, as required 
by the South African Biodiversity Act, 2004. The case studies discussed for Lippia javanica, 
Monsonia angustifolia, Siphonochilus aethiopicus, Elephantorrhiza elephantina and Schlerochiton 
ilicifolius are clear examples that TK is also important for innovation to grow and development the 
Bio-economy sector.
